Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,819 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.
Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T. Fukuokaya W, et al. Among authors: kitamura h. Int J Urol. 2024 Dec;31(12):1414-1422. doi: 10.1111/iju.15585. Epub 2024 Sep 18. Int J Urol. 2024. PMID: 39291802
Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.
Nishiyama N, Kitamura H, Hotta H, Takahashi A, Yanase M, Itoh N, Tachiki H, Miyao N, Matsukawa M, Kunishima Y, Taguchi K, Masumori N. Nishiyama N, et al. Among authors: kitamura h. Jpn J Clin Oncol. 2014 Nov;44(11):1101-8. doi: 10.1093/jjco/hyu119. Epub 2014 Aug 19. Jpn J Clin Oncol. 2014. PMID: 25139163
Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study.
Nishiyama N, Hotta H, Takahashi A, Yanase M, Itoh N, Tachiki H, Miyao N, Matsukawa M, Kunishima Y, Taguchi K, Kitamura H, Masumori N. Nishiyama N, et al. Among authors: kitamura h. Urol Oncol. 2018 Jun;36(6):306.e9-306.e15. doi: 10.1016/j.urolonc.2018.02.009. Epub 2018 Mar 15. Urol Oncol. 2018. PMID: 29550096
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.
Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C. Okita K, et al. Among authors: kitamura h. Clin Genitourin Cancer. 2019 Jun;17(3):e440-e446. doi: 10.1016/j.clgc.2019.01.006. Epub 2019 Jan 17. Clin Genitourin Cancer. 2019. PMID: 30772204
1,819 results